Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Scinai Immunotherapeutics Ltd SCNI

Healthcare Biotechnology
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:SCNI)

Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million

PR Newswire 10 hours ago

Scinai Leadership to Showcase Company's cGMP Biologics CDMO and Innovative I&I pipeline during BIO-Europe 2024

PR Newswire October 31, 2024

Scinai to Host Online Expert Panel on Plaque Psoriasis Treatment and Intralesional Injections of anti-IL-17A/F VHH Antibodies

PR Newswire September 16, 2024

Scinai Regains Full Compliance with Nasdaq Listing Requirements

PR Newswire August 29, 2024

Scinai Announces Closing of Loan Restructuring Agreement with European Investment Bank Converting Approximately $29 million of Debt to Preferred Equity and Leaving Debt Balance of $273,000

PR Newswire August 21, 2024

Scinai Announces Entering into $2 Million Private Equity Commitment Agreement with its largest Existing Shareholder

PR Newswire August 20, 2024

Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to Equity; On Track to Regain Nasdaq Compliance by August 23

PR Newswire August 15, 2024

Scinai Announces Signing of Loan Restructuring Agreement with European Investment Bank; Converting Approximately $29 million of Debt to Preferred Equity Convertible into 19.5% Common Equity

PR Newswire August 13, 2024

Scinai Immunotherapeutics Announces Positive Regulatory Feedback from the PEI on the path for Phase 1/2a in Plaque Psoriasis with its anti-IL-17 nanoAb

PR Newswire July 23, 2024
View More News ››

Opinion & Analysis (NDAQ:SCNI)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:SCNI)

InvestorNewsBreaks - Scinai Immunotherapeutics Ltd. (NASDAQ:

BREAKING NEWS: $SCNI InvestorNewsBreaks - Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Schedules Virtual Panel Discussion on Plaque...
whytestocks - September 16, 2024

InvestorNewsBreaks -&#xA0;Scinai Immunotherapeutics Ltd. (NA

BREAKING NEWS: $SCNI InvestorNewsBreaks -&#xA0;Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), EIB Close on Loan Restructuring...
whytestocks - August 21, 2024

Scinai Announces Entering into $2 Million Private Equity Com

News; $SCNI Scinai Announces Entering into $2 Million Private Equity Commitment Agreement with its largest Existing ShareholderScinai...
whytestocks - August 20, 2024

InvestorNewsBreaks - Scinai Immunotherapeutics Ltd. (NASDAQ:

BREAKING NEWS: $SCNI InvestorNewsBreaks - Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports Q2 2024 Financial Results, Shares...
whytestocks - August 15, 2024

SCNI....DEBT to Equity conversion..... Sheesh

You will all get screwed.....go ahead and be a CHaser !!!! Now at $6.20.....watch out !!!!!!!!!!!!!!!!!!!!!!!!
Iseneschal - June 17, 2024

NIH Researchers Unveil AI Tool to Predict Oncology Patients'

NEWS: $SCNI NIH Researchers Unveil AI Tool to Predict Oncology Patients' Response to ImmunotherapyScientists at the National...
whytestocks - June 7, 2024
View more Bullboard ››

FPX Nickel Corp.

FPX Nickel Corp.

FPX Nickel Corp. is a Canada-based junior nickel mining company. The Company is focused on the exploration and development of ...
View More »